Download PDF
Geburtshilfe Frauenheilkd 2004; 64(1): R1-R16
DOI: 10.1055/s-2004-820855
GebFra-Refresher

Georg Thieme Verlag Stuttgart · New York

Endogene Steuerung der Ovarialfunktion - Teil 1

B. Sonntag1 , L. Kiesel1
  • 1Münster
Further Information

Publication History

Publication Date:
19 January 2004 (online)

Also available at
    Permissions and Reprints

Grundlagen

Die physiologische Funktion des Ovars, gekennzeichnet durch die Bereitstellung der Eizellen sowie Produktion der Sexualhormone Östradiol und Progesteron, bildet die Grundlage weiblicher Fertilität. Beide Prozesse sind eng miteinander verwoben und während der reproduktiven Jahre in optimaler Weise aufeinander abgestimmt. Der Menstruationszyklus - auf ovarieller Ebene unterteilt in Follikelreifung, Ovulation und Gelbkörperphase - ist Ausdruck dieses mit großer Regelmäßigkeit ablaufenden Geschehens. Das Verständnis der Steuerung dieses Prozesses ist Grundlage für die Diagnostik eventuell auftretender Störungen.

Literatur

  • 1 Suh C S, Sonntag B, Erickson G F. Ovarian life cycle: a contemporary view.  Rev Endocr Metab Disord. 2002;  3 5-12
    CrossrefPubMedGoogle Scholar
  • 2 Ohno S, Smith J B. Role of fetal follicular cells in meiosis of mammalian oocytes.  Cytogenetics. 1964;  3 324-333
    PubMedGoogle Scholar
  • 3 Vainio S, Heikkila M, Kispert A, Chin N, McMahon A P. Female development in mammals is regulated by Wnt-4 signaling.  Nature. 1999;  397 405-409
    CrossrefPubMedGoogle Scholar
  • 4 Durlinger A L, Gruijters M J, Kramer P, Karels B, Ingraham H A, Nachtigal M W, Uilenbroek J T, Grootegoed J A, Themmen A P. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.  Endocrinology. 2002;  143 1076-1084
    CrossrefPubMedGoogle Scholar
  • 5 Fortune J E, Cushman R A, Wahl C M, Kito S. The primordial to primary follicle transition.  Mol Cell Endocrinol. 2000;  163 53-60
    CrossrefPubMedGoogle Scholar
  • 6 Yoshida H. 6 . Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development.  Dev Biol. 1997;  184 122-137
    CrossrefPubMedGoogle Scholar
  • 7 Dong J, Albertini D F, Nishimori K, Kumar T R L N, Matzuk M. Growth differentiation factor-9 is required during early ovarian folliculogenesis.  Nature. 1996;  383 531-535
    CrossrefPubMedGoogle Scholar
  • 8 Kumar T R, Wang Y, Lu N, Matzuk M M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.  Nat Genet. 1997;  15 201-204
    CrossrefPubMedGoogle Scholar
  • 9 Frisch R E, McArthur J W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset.  Science. 1974;  185 949-951
    PubMedGoogle Scholar
  • 10 de Muinich Keizer S M, Mul D. Trends in pubertal development in Europe.  Hum Reprod Update. 2001;  7 287-291
    CrossrefPubMedGoogle Scholar
  • 11 Catzeflis C, Pierroz D D, Rohner-Jeanrenaud F, Rivier J E, Sizonenko P C, Aubert M L. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.  Endocrinology. 1993;  132 224-234
    CrossrefPubMedGoogle Scholar
  • 12 Campfield L A, Smith F J, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.  Science. 1995;  269 546-549
    CrossrefPubMedGoogle Scholar
  • 13 Richardson S J, Senikas V, Nelson J F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.  J Clin Endocrinol Metab. 1987;  65 1231-1237
    CrossrefPubMedGoogle Scholar
  • 14 Knobil E. The neuroendocrine control of the menstrual cycle.  Recent Prog Horm Res. 1980;  36 53-88
    PubMedGoogle Scholar
  • 15 Filicori M, Santoro N, Merriam G R, Crowley Jr W F. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.  J Clin Endocrinol Metab. 1986;  62 1136-1144
    PubMedGoogle Scholar
  • 16 Conn P M, Crowley Jr W F. Gonadotropin-releasing hormone and its analogs.  Annu Rev Med. 1994;  45 391-405
    CrossrefPubMedGoogle Scholar
  • 17 Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses.  Endocr Rev. 1996;  17 121-155
    CrossrefPubMedGoogle Scholar
  • 18 Falck B. Site of production of oestrogen in rat ovary as studied in micro-transplants.  Acta Physiol Scand. 1959;  47 1-101
    PubMedGoogle Scholar
  • 19 Tilly J L, LaPolt P S, Hsueh A J. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells.  Endocrinology. 1992;  130 1296-1302
    CrossrefPubMedGoogle Scholar
  • 20 Erickson G F, Wang C, Hsueh A J. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium.  Nature. 1979;  279 336-338
    PubMedGoogle Scholar
  • 21 Mayerhofer A, Dimitrijevic N, Kunz L. The expression and biological role of the non-neuronal cholinergic system in the ovary.  Life Sci. 2003;  72 2039-2045
    CrossrefPubMedGoogle Scholar
  • 22 Liu J P, Baker J, Perkins A S, Robertson E J, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1 r).  Cell. 1993;  75 59-72
    PubMedGoogle Scholar
  • 23 Erickson G F, Garzo V G, Magoffin D A. Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells.  J Clin Endocrinol Metab. 1989;  69 716-724
    PubMedGoogle Scholar
  • 24 Nakatani A, Shimasaki S, Erickson G F, Ling N. Tissue-specific expression of four insulin-like growth factor-binding proteins (1, 2, 3, and 4) in the rat ovary.  Endocrinology. 1991;  129 1521-1529
    PubMedGoogle Scholar
  • 25 Cataldo N A, Giudice L C. Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status.  J Clin Endocrinol Metab. 1992;  74 821-829
    CrossrefPubMedGoogle Scholar
  • 26 Hourvitz A, Widger A E, Filho F L, Chang R J, Adashi E Y, Erickson G F. Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea.  J Clin Endocrinol Metab. 2000;  85 4916-4920
    CrossrefPubMedGoogle Scholar
  • 27 Rivera G M, Fortune J E. Proteolysis of insulin-like growth factor binding proteins -4 and - 5 in bovine follicular fluid: implications for ovarian follicular selection and dominance.  Endocrinology. 2003;  144 2977-2987
    CrossrefPubMedGoogle Scholar
  • 28 Erickson G F, Shimasaki S. The role of the oocyte in folliculogenesis.  Trends Endocrinol Metab. 2000;  11 193-198
    PubMedGoogle Scholar
  • 29 Channing C P. Influences of the in vivo and in vitro hormonal environment upon luteinization of granulosa cells in tissue culture.  Recent Prog Horm Res. 1970;  26 589-622
    PubMedGoogle Scholar
  • 30 Vitt U A, Hayashi M, Klein C, Hsueh A JW. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles.  Biol Reprod. 2000;  62 370-377
    PubMedGoogle Scholar
  • 31 Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson G F, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions.  J Biol Chem. 2000;  275 39523-39528
    CrossrefPubMedGoogle Scholar
  • 32 Otsuka F, Yamamoto S, Erickson G F, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression.  J Biol Chem. 2001;  276 11387-11392
    CrossrefPubMedGoogle Scholar

Klaus Vetter

Klinik für Geburtsmedizin
Vivantes Klinikum Neukölln

Mariendorfer Weg 28

12051 Berlin

Email: klaus.vetter@vivantes.de

      >